60
Views
0
CrossRef citations to date
0
Altmetric
Research Article

α-Amylase and α-Glucosidase Enzyme Inhibition, Molecular Docking, and Pharmacokinetic Studies of Natural Products from Dilenia indica L. Barks

, , , &
Pages 265-283 | Received 03 May 2023, Accepted 30 Jun 2023, Published online: 24 Aug 2023

References

  • Davey, G.C., Patil, S.B., O’Loughlin, A. and O’Brien, T. (2014). Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Front. Endocrinol. (Lausanne) 5: 86. doi: 10.3389/fendo.2014.00086
  • Warjeet, L. (2011). Tradtional medicinal plants of Manipur as anti-diabetics. J. Med. Plants Res. 5: 677-687.
  • Kumar, A., Archo, S., Singh, C.P., Singh, B., Kaur, S. and Abdullah, S.T. (2022). Photoprotective effect of 18β-glycyrrhetinic acid derivatives against ultra violet (UV)-B-Induced skin aging. Bioorg. Med. Chem. Lett. 76: 128984. doi: 10.1016/j.bmcl.2022.128984
  • Kumar, A., Kaur, S., Sangwan, P.L. and Abdullah, S.T. (2023). Therapeutic and cosmeceutical role of glycosylated natural products in dermatology, Phytother. Res. 1–16.
  • Ogurtsova, K., da Rocha Fernandes, J., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N., Cavan, D., Shaw, J. and Makaroff, L. (2017). IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 128: 40-50. doi: 10.1016/j.diabres.2017.03.024
  • Forbes, J.M. and Cooper, M.E. (2013). Mechanisms of diabetic complications. Physiol. Rev. 93: 137-188. doi: 10.1152/physrev.00045.2011
  • Papatheodorou, K., Papanas, N., Banach, M., Papazoglou, D. and Edmonds, M. (2016). Complications of Diabetes 2016. J. Diabetes Res. 2016. doi: 10.1155/2016/6989453
  • Rahimi, K. (2016). The Long and Unfinished Journey of Hyperglycaemia and Heart Failure Research. BMJ Publishing Group Ltd and British Cardiovascular Society.
  • Teupe, C. and Rosak, C. (2012). Diabetic cardiomyopathy and diastolic heart failure difficulties with relaxation. Diabetes Res. Clin. Pract. 97: 185-194. doi: 10.1016/j.diabres.2012.03.008
  • Solomon, S.D., Chew, E., Duh, E.J., Sobrin, L., Sun, J.K., VanderBeek, B.L., Wykoff, C.C. and Gardner, T.W. (2017). Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 40: 412-418. doi: 10.2337/dc16-2641
  • Pop-Busui, R., Boulton, A.J., Feldman, E.L., Bril, V., Freeman, R., Malik, R.A., Sosenko, J.M. and Ziegler, D. (2017). Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 40: 136-154. doi: 10.2337/dc16-2042
  • Hroob, A.A., Abukhalil, M., Alghonmeen, R. and Mahmoud, A. (2018). Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy. Biomed. Pharmacother. 106: 381. doi: 10.1016/j.biopha.2018.06.148
  • Long, A.N. and Jack, S.D. (2011). Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J. Clin. Hypertens. 13: 244-251. doi: 10.1111/j.1751-7176.2011.00434.x
  • Leon, B.M. and Maddox, T.M. (2015). Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J. Diabetes 6: 1246. doi: 10.4239/wjd.v6.i13.1246
  • Loizzo, M.R., Saab, A.M., Tundis, R., Menichini, F., Bonesi, M., Piccolo, V., Statti, G.A., de Cindio, B., Houghton, P.J. and Menichini, F. (2008a). In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. J. Ethnopharmacol. 119: 109-116. doi: 10.1016/j.jep.2008.06.003
  • Narkhede, M.B. (2011). Investigation of in-vitro a-amylase and a-glucosidase inhibitory activity of polyherbal extract. Int. J. Pharm. Res. 97: 97-103.
  • Kotowaroo, M.I., Mahomoodally, M.F., Gurib-Fakim, A., Subratty, A.H. (2006). Screening of traditional antidiabetic medicinal plants of Mauritius for possible a-amylase inhibitory effects in-vitro. Phytother. Res. 228-231. doi: 10.1002/ptr.1839
  • Kwon, Y.I.I., Vattem, D.A. and Shetty, K. (2006). Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia. Pac. J. Clin. Nutr. 15: 107-118.
  • Lebovitz, H.E. (1997). a-glucosidase inhibitors. Endocrinol. Metab. Clin. North. Am. 26: 539-551. doi: 10.1016/S0889-8529(05)70266-8
  • Franco, O.L., Rigden, D.J., Melo, F.R. and Grossi-de-S, M.F. (2002). Plant a-amylase inhibitors and their interaction with insect a-amylases: structure, function and potential for crop protection. Eur. J. Biochem. 269: 397-412. doi: 10.1046/j.0014-2956.2001.02656.x
  • Kumar, S., Narwal, S., Kumar, V. and Prakash, O. (2011). a-glucosidase inhibitors from plants: a natural approach to treat diabetes. Pharmacogn. Rev. 5: 19-29. doi: 10.4103/0973-7847.79096
  • Venkatesh, S., Reddy, G.D., Reddy, B.M., Ramesh, M. and Appa Rao, A.V.N. (2003). Anti-hyperglycaemic activity of Caralluma attenuata. Fitoterapia. 74: 274-179. doi: 10.1016/S0367-326X(03)00021-2
  • Chopade, B.A., Ghosh, S. and Ahire, M. (2012). Anti-diabetic activity of gnidia glauca and dioscorea bulbifera: potent amylase and glucosidase inhibitors. Evid. Based Complement Alternat. Med. 10.
  • Yazan, S.L. and Armania, N. (2014). Dillenia species: A review of the traditional uses, active constituents and pharmacological properties from pre-clinical studies. Pharm. Biol. 52: 890-897. doi: 10.3109/13880209.2013.872672
  • Jiaqi, H., Bin, W., Fang, Xu. and Jie, O. (2017). Chemical Constituents of Essential Oils from Chestnut Flowers. J. Essent. Oil-Bear. Plants. 20: 502-508. doi: 10.1080/0972060X.2017.1326848
  • Huxley, A. (1992). New RHS Dictionary of Gardening. London and Basingstoke: Macmillan Press.
  • Giampieri, F., Forbes-Hernandez, T.Y., Gasparrini, M., Alvarez-Suarez, J.M., Afrin, S., Bompadre, S., Quiles, J.L., Mezzetti, B. and Battino, M. (2015). Strawberry as a health promoter: An evidence based review. Food Funct. 6: 1386-1398. doi: 10.1039/C5FO00147A
  • Hossain, M.K., Dayem, A.A., Han, J., Yin, Y., Kim, K., Saha, S.K., Yang, G.M., Choi, H.Y. and Cho, S.G. (2016). Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids. Int. J. Mol. Sci. 17: 569. doi: 10.3390/ijms17040569
  • Gooda Sahib, N., Saari, N., Ismail, A., Khatib, A., Mahomoodally, F. and Abdul Hamid, A. (2012). Plants metabolites as potential anti-obesity agents. Sci. World J. Article ID 436039.
  • Singh, P.A. and Vidhu, A. (2016). Physico-chemical parameters and HPTLC fingerprinting profile of D. indica Miq. f. Elongata (Miq.) and Tectona grandis Linn. with reference to betulin. Int. J. Pharm. Bio Sci. 7: 217-221. doi: 10.22376/ijpbs.2016.7.4.p163-173
  • Jaiswal, S., Mansa, N., Prasad, P., Jena, B.S. and Negi, P.S. (2014). Anti-bacterial and anti-mutagenic activities of D. indica extracts. Food. Bio. Org. Sci. 5: 47-53.
  • Yeshwante, S.B., Juvekar, A.R., Nagmoti, D.M., Wankhede, S.S., Shah, A.S., Pimprikar, R.B. and Saindane, D.S. (2009b). Anti-inflammatory activity of methanolic extracts of D. indica Linn. Leaves. J. Young Pharm. 1: 63-66. doi: 10.4103/0975-1483.51885
  • Somani, S.J., Badgujar, L.B., Sutariya, B.K. and Saraf, M.N. (2014). Protective effect of D. indica L. on acetic acid induced colitis in mice. Ind. J. Exp. Biol. 52: 876-881.
  • Kumar, S., Kumar, V. and Prakash, O. (2011a). Anti-diabetic and hypolipidemic activities of D. indica (L.) extract in diabetic rats. Chin. J. Int. Med. 9: 570-574. doi: 10.3736/jcim20110517
  • Kumar, S., Kumar, V. and Prakash, O. (2011b). Anti-diabetic and anti-hyper-lipidemic effects of D. indica (L.) leaves extract. Braz. J. Pharm. Sci. 47: 373-378. doi: 10.1590/S1984-82502011000200018
  • Bhadra, S., Dalai, M.K., Chandra, J., Kar, A. and Mukherjee, P.K. (2014). Screening of anti-cholinesterase activity of the standardized extract of D. indica fruits. Eur. J. Int. Med. 6: 686-687.
  • Padhya, I.P., Choudhary, N.S., Padhy, S.K. and Das, S. (2008). Effect of D. indica leaves against carbon tetrachloride induced hepatotoxicity. J. Pharm. Chem. 2: 190-193.
  • Himakar, R.K., Tharanath, V., Nagi, R.K.B., Sharma, P.V.G.K. and Reddy, O.V.S. (2010). Studies on hepatoprotective effect of hexane extract of D. indica against CCl4 induced toxicity and its safety evaluation in Wistar albino rats. Res. J. Pharm. Biol. Chem. Sci. 1: 441-450.
  • Kumar, D., Mallick, S., Vedasiromoni, J.R. and Pal, B.C. (2010). Anti-leukemic activity of D. indica L. fruit and quantification of betulinic acid by HPLC. Phytomed. 17: 431-435. doi: 10.1016/j.phymed.2009.07.010
  • Deepa, N. and Jena, B.S. (2011). Anti-oxidant extract from bark of D. indica. Int. J. Food Prop. 14: 1152-1159. doi: 10.1080/10942911003592779
  • Alam, M.B., Rahman, M.S., Hasan, M., Khan, M.M., Nahar, K. and Sultana, S. (2012). Anti-nociceptive and antioxidant activities of the D. indica bark. Int. J. Pharmacol. 8: 243-251. doi: 10.3923/ijp.2012.243.251
  • Jin, K.S., Oh, Y.N., Hyun, S.K., Kwon, H.J. and Kim, B.W. (2014). Betulinic acid isolated from Vitis amurensis root inhibits 3-isobutyl-1-methylxanthine induced melanogenesis via the regulation of MEK/ERK and PI3K/Akt pathways in B16F10 cells. Food Chem. Toxicol. 68: 38-43. doi: 10.1016/j.fct.2014.03.001
  • Kumar, S., Kumar, V. and Prakash, O. (2011). Anti-diabetic, hypolipidemic and histopathological analysis of D. indica (L.) leaves extract on alloxan induced diabetic rats. Asian Pac. J. Trop. Med. 4: 347-352. doi: 10.1016/S1995-7645(11)60101-6
  • Kumar, S., Kumar, V. and Prakash, O. (2011). Anti-diabetic and anti-hyperlipidemic effects of D. indica (L.) leaves extract. Braz. J. Pharm. Sci. 47: 373-378. doi: 10.1590/S1984-82502011000200018
  • Evans, W.C. (2002). Trease and Evans Pharmacognosy, WB Saunders Ltd 3rd Ed. Lond. 32-33.
  • Kokoski, C.J., Kokoski, R.J. and Frank, J.S. (1958). Fluorescence of powdered vegetable drugs under ultraviolet radiation. J. Am. Pharm. Assoc. 47: 715-717. doi: 10.1002/jps.3030471010
  • Trease, G.E. and Evans, W.C. (1983). Pharmaognosy 12th edition East bourne: Balliere Tindall. 46-53.
  • Shoichet, B.K. and Kuntz, I.D. (1991). Protein docking and complementarity. J. Mol. Biol. 221: 327-346. doi: 10.1016/0022-2836(91)80222-G
  • Proudfoot, J.R. (2002). Drugs, leads and drug-likeness: an analysis of some recently launched drugs. Bioorg. Med. Chem. Lett. 12: 1647-1650. doi: 10.1016/S0960-894X(02)00244-5
  • Ding, H., Wu, X., Pan, J., Hu, X., Gong, D. and Zhang, G. (2018). New insights into the inhibition mechanism of betulinic acid on α-glucosidase. J. Agric. Food. Chem. 66: 7065-7075. doi: 10.1021/acs.jafc.8b02992
  • Alqahtani, A.S., Hidayathulla, S., Rehman, M.T., El-Gamal, A.A., Al-Massarani, S., Razmovski-Naumovski, V., Alqahtani, M.S., El-Dib, R.A. and Al-Ajmi, M.F. (2020). Alpha-amylase and alpha-glucosidase enzyme inhibition and antioxidant potential of 3-oxolupenal and katononic acid isolated from Nuxia oppositifolia. Biomolecules. 10: 61. doi: 10.3390/biom10010061
  • Hansawasdi, C., Kawabata, J. and Kasai, T. (2000). a-amylase inhibitors fromroselle (Hibiscus sabdariffa Linn.) tea. Biosci. Biotechnol. Biochem. 64: 1041-1043. doi: 10.1271/bbb.64.1041
  • Kim, J.S., Yang, J. and Kim, M.J. (2011). a-glucosidase inhibitory effect, anti-microbial activity and UPLC analysis of Rhus verniciflua under various extract conditions. J. Med. Plant Res. 5: 778-783.
  • Gupta, M., Lee, H.J., Barden, C.J. and Weaver, D.F. (2019). The Blood-Brain barrier (BBB) score. J. Med. Chem. 62: 9824-9836. doi: 10.1021/acs.jmedchem.9b01220
  • Khan, O.A., Gore, M., Lorigan, P., Stone, J., Greystoke, A., Burke, W., Carmichael, J., Watson, A.J., McGown, G. and Thorncroft, M. (2011). A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br. J. Canc. 104: 750-755. doi: 10.1038/bjc.2011.8
  • Elshaymaa, I.E. and Hanan, A.H. (2022). In-silico evaluation of a promising key intermediate thieno [2,3-d] pyrimidine derivative with expected JAK2 kinase inhibitory activity. Molbank. 1: M1352.
  • Sakulkeo, O., Wattanapiromsakul, C., Pitakbut, T. and Dej-adisai, S. (2022). Alpha-glucosidase inhibition and molecular docking of isolated compounds from traditional thai medicinal plant, Neuropeltis racemosa Wall. Molecules. 27: 639. doi: 10.3390/molecules27030639
  • Yang, J., Qiu, B., Li, X., Zhang, H. and Liu, W. (2015). p53-p66 (shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma. Toxicol. Lett. 238: 1-10. doi: 10.1016/j.toxlet.2015.07.016

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.